VCAM1 and Alzheimer disease: In one of the studies, the plasma levels of VCAM-1 measured by ELISA in patients with AD (708 ng/ml), as well as in patients with vascular dementia (728 ng/ml), were increased by 1.3 times compared to non-demented control patients (562 ng/ml) [115].